"Aminolevulinic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
| Descriptor ID |
D000622
|
| MeSH Number(s) |
D02.241.755.547.276 D12.125.262
|
| Concept/Terms |
Aminolevulinic Acid- Aminolevulinic Acid
- Acid, Aminolevulinic
- Delta-Aminolevulinic Acid
- Acid, Delta-Aminolevulinic
- Delta Aminolevulinic Acid
|
Below are MeSH descriptors whose meaning is more general than "Aminolevulinic Acid".
Below are MeSH descriptors whose meaning is more specific than "Aminolevulinic Acid".
This graph shows the total number of publications written about "Aminolevulinic Acid" by people in this website by year, and whether "Aminolevulinic Acid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 0 | 1 | 1 |
| 1993 | 0 | 1 | 1 |
| 1995 | 4 | 1 | 5 |
| 1996 | 3 | 1 | 4 |
| 1997 | 3 | 1 | 4 |
| 1998 | 8 | 3 | 11 |
| 1999 | 3 | 1 | 4 |
| 2000 | 11 | 2 | 13 |
| 2001 | 18 | 2 | 20 |
| 2002 | 26 | 7 | 33 |
| 2003 | 20 | 8 | 28 |
| 2004 | 26 | 12 | 38 |
| 2005 | 27 | 13 | 40 |
| 2006 | 27 | 5 | 32 |
| 2007 | 41 | 21 | 62 |
| 2008 | 52 | 14 | 66 |
| 2009 | 44 | 16 | 60 |
| 2010 | 59 | 21 | 80 |
| 2011 | 57 | 15 | 72 |
| 2012 | 50 | 14 | 64 |
| 2013 | 66 | 12 | 78 |
| 2014 | 65 | 16 | 81 |
| 2015 | 60 | 27 | 87 |
| 2016 | 61 | 21 | 82 |
| 2017 | 58 | 21 | 79 |
| 2018 | 59 | 33 | 92 |
| 2019 | 14 | 8 | 22 |
| 2020 | 0 | 2 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Aminolevulinic Acid" by people in Profiles.
-
Posterior Reversible Encephalopathy Syndrome. Curr Pain Headache Rep. 2021 Feb 25; 25(3):19.
-
Sars-Cov-2 interference in HEME production: is it the time for an early predictive biomarker? J Mol Med (Berl). 2020 08; 98(8):1053-1054.
-
Endoscopic Fluorescence-Guided Resection Increases Radicality in Glioblastoma Surgery. Oper Neurosurg (Hagerstown). 2020 01 01; 18(1):41-46.
-
Evaluation of human papillomavirus DNA detection-guided aminolaevulinic acid-mediated photodynamic therapy for the treatment of condyloma acuminata. Photodiagnosis Photodyn Ther. 2019 Dec; 28:114-119.
-
Photodynamic therapy enhances skin cancer chemotherapy effects through autophagy regulation. Photodiagnosis Photodyn Ther. 2019 Dec; 28:159-165.
-
Photodynamic therapy in a patient with facial angiofibromas due to tuberous sclerosis complex. Photodiagnosis Photodyn Ther. 2019 Dec; 28:183-185.
-
Photodynamic therapy for oral potentially malignant disorders. Photodiagnosis Photodyn Ther. 2019 Dec; 28:146-152.
-
Biosensor device for the photo-specific detection of immuno-captured bladder cancer cells using hexaminolevulinate: An ex-vivo study. Photodiagnosis Photodyn Ther. 2019 Dec; 28:238-247.
-
Quantification of PpIX-fluorescence of cerebral metastases: a pilot study. Clin Exp Metastasis. 2019 10; 36(5):467-475.
-
Hyperostosis and osteolysis in skull base meningiomas: are different nuances of 5-ALA fluorescence related to different invasion patterns? J Neurosurg Sci. 2019 08; 63(4):484-485.